SCHEMBL24848129

SCHEMBL24848129

CC(C)[C@H](NC(=O)CCCCN1C(=O)C=CC1=O)C(=O)N[C@@H](CCCNC(N)=O)C(=O)Nc1ccc(CO)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAP Q12884 5/20 0.44
▸ NPY5R Q15761 4/20 0.37
▸ NPY4R P50391 4/20 0.37
▸ NPY1R P25929 3/20 0.37
▸ NPY2R P49146 1/20 0.37
▸ FURIN P09958 2/20 0.37
▸ MAP1LC3B Q9GZQ8 2/20 0.35
▸ ROCK2 O75116 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ HDAC3 O15379 1/20 0.34
▸ HDAC4 P56524 1/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC7 Q8WUI4 1/20 0.34
▸ HDAC2 Q92769 1/20 0.34
▸ HDAC10 Q969S8 1/20 0.34
▸ HDAC11 Q96DB2 1/20 0.34
▸ HDAC8 Q9BY41 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ HDAC9 Q9UKV0 1/20 0.34
▸ HDAC5 Q9UQL6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21416485 0.99 FAP (0.44) FAPNPY5RNPY4RNPY1RNPY2R
SCHEMBL16266184 0.99 FAP (0.44) FAPNPY5RNPY4RNPY1RNPY2R
SCHEMBL15246622 0.99 FAP (0.44) FAPNPY5RNPY4RNPY1RNPY2R
SCHEMBL3244447 0.99 FAP (0.44) FAPNPY5RNPY4RNPY1RNPY2R
SCHEMBL23286101 0.98 FAP (0.42) FAPNPY5RNPY4RNPY1RNPY2R
SCHEMBL18244335 0.95 FAP (0.40) FAPNPY5RNPY4RNPY1RNPY2R
SCHEMBL18244334 0.95 FAP (0.40) FAPNPY5RNPY4RNPY1RNPY2R
SCHEMBL26423172 0.93 FAP (0.42) FAPNPY5RNPY4RNPY1RNPY2R
SCHEMBL22952275 0.93 FAP (0.44) FAPNPY5RNPY4RNPY1RNPY2R
SCHEMBL24520454 0.93 FAP (0.47) FAPNPY5RNPY4RNPY1RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023278592-A1 RADIOLABELED PARP INHIBITOR CONJUGATES FOR CANCER TREATMENT DUKE UNIVERSITY (US) 2023-01-05 — — WO disclosed
Send feedback